In furtherance to its earlier intimation dated 23rd January, 2026 with regard to conference call to discuss the Q3FY26 and 9MFY26 financial results to held on Friday, February 13, 2026 at 4:00 pm. With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that a conference call to discuss the Q3FY26 and 9MFY26 financial results will now be held on Friday, February 13, 2026 at 5.00 pm. The company has enclosed the updated conference call details.
The above information is a part of company’s filings submitted to BSE.
